medline.ch Onkologie Urologische Tumoren

	Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [(177)Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy. J Nucl Med Zhao R, Li M, Lv J, Zhang J, Zhong H, Fu Y, Liu J, Gu D, Zeng G, Kung HF, Zhu L, Huang J, Wang X. PMID: 42785946 [PubMed - as supplied by publisher]
	Toward precision adjuvant immunotherapy in high-risk clear cell renal cell carcinoma: integrating plasma multiomics with PD-1 blockade. J Immunother Cancer Kumar R, Hewa Angappulige D, Song J. PMID: 42785920 [PubMed - indexed for MEDLINE]
	HER1-HER4 expression and co-expression in advanced urothelial carcinoma. ESMO Open Coca Membribes S, Berney DM, Beltran L, Nally E, Jackson-Spence F, Szabados B, Mariathasan S, Powles T, Ackerman C. PMID: 42785914 [PubMed - indexed for MEDLINE]
	Renal synovial sarcoma occurring synchronously with renal cell carcinoma. BMJ Case Rep Manchanda D, Krishna A, Nayak R, Kini H. PMID: 42785769 [PubMed - indexed for MEDLINE]
	Corrigendum to "Prediction of Distant Metastasis in Renal Cell Carcinoma Using Machine Learning Algorithms: A Multicenter Cohort Study". Cancer Control PMID: 42784720 [PubMed - in process]
	Precision Diagnostics in Prostate Cancer: Integrating Biomarkers, Imaging, Genomics, and Artificial Intelligence in Contemporary United States Practice. Med Sci (Basel) Kardjadj M. PMID: 42783413 [PubMed - indexed for MEDLINE]
	Prognostic Value of a Novel Risk Score Combining Psoas Muscle Density and ALBI Grade in Localized Renal Cell Carcinoma. Med Sci (Basel) Makino T, Izumi K, Nakagawa R, Kamijima T, Kadomoto S, Naito R, Iwamoto H, Yaegashi H, Shigehara K, Nohara T, Mizokami A. PMID: 42783382 [PubMed - indexed for MEDLINE]
	Label-Free Refractive-Index-Based Detection of Breast, Leukemia, and Prostate Cancer Cells Using a Tetra-Core PCF SPR Biosensor. Biosensors (Basel) Shakya AK, Grigalavi. PMID: 42783130 [PubMed - indexed for MEDLINE]
	Patient Perspectives on Prostate Cancer Prehabilitation: A Qualitative Study Using the Behaviour Change Wheel to Investigate Barriers and Facilitators to Engagement. Curr Oncol Harsanyi H, Slot N, Housten AJ, Lee YY, Hyndman ME, Yang L. PMID: 42782910 [PubMed - indexed for MEDLINE]
	Incremental Value of PI-RADS v2.1 for Adverse Pathology at Radical Prostatectomy: A Retrospective 1.5-T MRI Cohort. Curr Oncol Kayali Y, Erdemoglu O, Akyol YK, Colak M, Torun A, Bicaklioglu F, Eryildirim B. PMID: 42782900 [PubMed - indexed for MEDLINE]
	From Availability to Access: A Mixed-Methods Study of Digital Prostate Cancer Survivorship Support for Black Men. Curr Oncol Okedara O, Ilie G, Brodovsky M, Mason RJ, Rendon R, Kokorovic A, Bailly G, Evans H, Jana K, Nayak JG, Chan E, Flax S, Patil N, Bowes D, Ramiah D, Mutambirwa S, Oberholzer A, Riley L, Cole J, Carruthers W, Taylar S, Rutledge RDH. PMID: 42782888 [PubMed - indexed for MEDLINE]
	Identifying Distinct Quality-of-Life Profiles in Prostate Cancer Patients: A Latent Profile Approach. Curr Oncol Cheng L. PMID: 42782879 [PubMed - indexed for MEDLINE]
	Tumour GDF-15 Expression and Clinical Outcomes in Intermediate-Risk Metastatic Clear-Cell Renal Cell Carcinoma Treated with Second-Line Nivolumab. Curr Oncol Akdogan O, Ogut B, Sutcuoglu O, Urganci M, Kahya BU, Isik Gonul I, Salimoglu HAB, Ugur Tuzcu T, Yazici O, Ozet A, Ozdemir N. PMID: 42782878 [PubMed - indexed for MEDLINE]
	Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System). Curr Oncol Ahmed Z, Sayyid R, Yazdanpanah O, Samaeekia R, Kalebasty AR, Lee DI, Shahait M. PMID: 42782877 [PubMed - indexed for MEDLINE]
	Real-World Outcomes of Second-Line Chemotherapy in Metastatic Urothelial Carcinoma. Curr Oncol Ç, Arvas H, Karao, Köylü B, Demir N, Balkaya Aykut G, , Y, Urakç, Bay, Selçukbiricik F, Baydar E, Tazebay BN, Yaz, Bakkal Temi Y, Çabuk D, Uygun K, Kefeli U. PMID: 42782876 [PubMed - indexed for MEDLINE]
	Initial Experience with MR-Guided or CT-Guided Stereotactic Body Radiotherapy for Prostate Cancer. Curr Oncol Barcelona MVN, Sanmamed Salgado N, Valencia EG, Berlin A, Glicksman R, Catton C, McPartlin A, Winter JD, Dang J, Kong V, Deng Y, Chung P. PMID: 42782851 [PubMed - indexed for MEDLINE]
	Triple detection of the tumor proteins p63, Ki-67 and Alpha-methylacyl-CoA racemase in the pathological diagnosis of prostate cancer. J Med Biochem Niu M, Zhao D, He R, Qin L, Li Z, Zhang S, Chen L. PMID: 42781326 [PubMed]
	Suspected Pembrolizumab-Associated Perinuclear Antineutrophil Cytoplasmic Antibody (p-ANCA) Vasculitis With Progressive Kidney Injury in a Patient With Metastatic Renal Cell Carcinoma and Limited Renal Reserve: A Diagnostic Challenge. Cureus Goshtaseb R, Luu Y, Sarmosyan K, Lopez L, Drakaki A. PMID: 42780982 [PubMed]
	Progression-free survival and objective response rate as a surrogate end point for overall survival in metastatic renal cell carcinoma: A systematic review and meta-analysis. Cancer Leong R, Chen D, Almasri L, Lum N, Xiao K, Soleimani M, Kollmannsberger CK, Raman S. PMID: 42779347 [PubMed - indexed for MEDLINE]
	Impact of BRCA alterations on Androgen Receptor pathway inhibition treatment outcome in advanced prostate cancer. Cancer Res Commun Chaudhary R, Urtishak KA, Gormley M, Lopez-Gitlitz A, Mundle S, Santiago-Walker A, McCarthy S, Shen F, Gotto GT. PMID: 42779090 [PubMed - as supplied by publisher]

Artikel 1 - 20 / 181675

Seite 1 von 9084

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung